Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

研究方向

Immunology/Inflammation 相关产品(4245)

  • GC63473 structure
    GC63473diABZI-C2-NH2
    CAS: 2137975-93-8

    diABZI-C2-NH2是一种含有伯胺功能的活性类似物,是一种 STING 激动剂。

  • GC63475 structure
    GC63475Deltamethrin-d5
    CAS: 2140301-99-9

    An internal standard for the quantification of deltamethrin

  • GC63480 structure
    GC63480Obafistat
    CAS: 2160582-57-8

    Obafistat 是一种有效的醛酮还原酶 AKR1C3 抑制剂,对人 AKR1C3 的 IC50 值为 1.2 nM。

  • GC63485 structure
    GC63485Afimetoran
    CAS: 2171019-55-7
    纯度: >98.00%

    Afimetoran是 toll 样受体拮抗剂,可用于炎症和自身免疫性疾病的研究。

  • GC63488 structure
    GC63488Ethaselen
    CAS: 217798-39-5
    纯度: >98.00%

    Ethaselen (BBSKE) 是具有口服活性的,选择性的硫氧还蛋白还原酶 (TrxR) 抑制剂,对野生型人 TrxR1 和大鼠 TrxR1 的 IC50 分别为 0.5 和 0.35 μM。Ethaselen 特异性结合哺乳动物 TrxR1 C 端活性位点中独特的硒代半胱氨酸-半胱氨酸氧化还原对。Ethaselen 是一种有机硒化合物,一种有效的抗肿瘤候选药物,可通过靶向 TrxR 对非小细胞肺癌 (NSCLC) 发挥有效抑制作用。

  • GC63493 structure
    GC63493ELOVL1-IN-1
    CAS: 2227482-41-7

    An inhibitor of ELOVL1

  • GC63506 structure
    GC63506Curcumin-β-D-glucuronide
    CAS: 227466-72-0

    Curcumin-β-D-glucuronide 是口服姜黄素后的主要代谢产物,存在于肝组织和门静脉血中。 Curcumin-β-D-glucuronide 可用于结肠癌的研究。

  • GC63508 structure
    GC63508R-(+)-Mono-desmethylsibutramine
    CAS: 229639-54-7

    R-(+)-Mono-desmethylsibutramine是Mono-desmethylsibutramine的R对映体。

  • GC63509 structure
    GC63509BPK-21
    CAS: 2305052-77-9

    BPK-21 是一种活性丙烯酰胺,通过阻断 ERCC3 功能来抑制 T 细胞活化。BPK-21 特异性靶向解旋酶 ERCC3 中的 C342。

  • GC63510 structure
    GC63510BPK-25
    CAS: 2305052-86-0
    纯度: >99.50%

    BPK-25 是一种活性丙烯酰胺,通过涉及共价蛋白参与的翻译后机制促进核小体重塑和脱乙酰化 (NuRD) 复合蛋白的降解。BPK-25 通过环状二核苷酸配体 cGAMP 抑制 TMEM173 激活。

  • GC63526 structure
    GC63526(S)-ErSO
    CAS: 2407860-34-6
    纯度: >99.00%

    (S)-ErSO 是一种右旋的 ErSO。(S)-ErSO 在MCF-7 没有效果。

  • GC63530 structure
    GC63530Acid Ceramidase-IN-1
    CAS: 2415225-30-6
    纯度: >99.00%

    Acid Ceramidase-IN-1 是一种有效的口服生物利用度酸性神经酰胺酶 (AC, ASAH-1) 抑制剂 (hAC IC50=0.166 μM)。Acid Ceramidase-IN-1 对小鼠具有良好的脑渗透性。

  • GC63535 structure
    GC63535ALV2
    CAS: 2438124-95-7
    纯度: >98.00%

    ALV2是一种有效和选择性的Helios降解剂,ALV2可以结合CRBN(IC 50 =0.57μM)。

  • GC63542 structure
    GC63542L-Histidine benzyl ester bistosylate
    CAS: 24593-59-7
    纯度: >99.00%

    L-Histidine benzyl ester bistosylate 可能在 HutP (一种 RNA 结合蛋白)的激活中发挥作用。

  • GC63551 structure
    GC63551AZD-CO-Ph-PEG4-Ph-CO-AZD
    CAS: 2569143-72-0
    纯度: >96.00%

    AZD-CO-Ph-PEG4-Ph-CO-AZD 是一种可用于抗体-siRNA 结合合成的 bis-β-lactam 连接子。

  • GC63553 structure
    GC63553PTPN22-IN-1
    CAS: 2580935-57-3
    纯度: >98.00%

    PTPN22-IN-1 是一种有效的 PTPN22 抑制剂 (IC50=1.4 µ Ki=0.50 µM)。PTPN22-IN-1 对 PTPN22 的选择性是类似磷酸酶的 7-10 倍。PTPN22-IN-1 增强体内抗肿瘤免疫反应。

  • GC63557 structure
    GC63557PW0787
    CAS: 2624131-45-7
    纯度: >98.50%

    PW0787 是一种有效的,选择性的,具有口服活性的,可透过血脑屏障的 GPR52 激动剂 (EC50=135 nM)。PW0787 抑制精神刺激行为。

  • GC63573 structure
    GC63573Cannabigerol monomethyl ether
    CAS: 29106-17-0
    纯度: >98.00%

    An Analytical Reference Standard

  • GC63586 structure
    GC63586FR054
    CAS: 35954-65-5

    FR054 is a novel inhibitor of the Hexosamine Biosynthetic Pathway (HBP) enzyme PGM3 with a remarkable anti-breast cancer effect.

  • GC63587 structure
    GC63587Dichlormid
    CAS: 37764-25-3
    纯度: >99.00%

    Dichlormid 是除草剂安全剂。Dichlormid 上调 ZmGST27 和 ZmMRP1 的表达并增加 ZmGT1。

  • GC63588 structure
    GC63588Palmitoyl glutamic acid
    CAS: 38079-66-2

    Palmitoyl glutamic acid (N-Palmitoyl-L-glutamic acid) 是一种酰基氨基酸,具有神经保护作用。Palmitoyl glutamic acid 用作化妆品原料。

  • GC63589 structure
    GC63589NSC668394
    CAS: 382605-72-3
    纯度: >95.00% / >98.00%

    NSC668394 是一种有效的 ezrin (Thr567) 磷酸化抑制剂,Kd 值为 12.59 μM。NSC668394 主要通过与 ezrin 结合来抑制 PKCΙ 导致的 ezrin T567 磷酸化。NSC668394 可用于预防肿瘤转移。

  • GC63591 structure
    GC63591Cirsilineol
    CAS: 41365-32-6

    Cirsilineol 是一种天然黄酮化合物,可选择性抑制肠道 CD4+ T 细胞中的 IFN-γ/STAT1/T-bet 信号。Cirsilineol 具有免疫抑制和抗肿瘤特性。Cirsilineol 显着改善三硝基苯磺酸 (TNBS) 诱导的小鼠 T 细胞介导的实验性结肠炎。

  • GC63592 structure
    GC63592LCS-1
    CAS: 41931-13-9
    纯度: >98.00%

    An inhibitor of SOD1